Confirming type 1 diabetes remotely
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study checks if type 1 diabetes can be confirmed through a remote process rather than in-person visits. It may help make follow-up care easier for people with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes or started insulin within 3 years of diagnosis.
- You are under the care of the diabetes team at the Royal Devon and Exeter NHS Foundation Trust.
- You have had diabetes for more than 3 years.
- You are 18 years old or older.
- Your care team thinks it is safe and appropriate for you to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way of managing type 1 diabetes remotely, where your glucose data is shared with your diabetes team. It aims to see if this approach helps you maintain good glucose control and reduces the need for frequent hospital visits.
This study is looking for people with type 1 diabetes to better understand the condition and how it may be managed. You might qualify if you were diagnosed by a specialist and are insulin-dependent under certain conditions.
This study tests a screening program to find early signs of type 1 diabetes in family members of people who have it. If you are a close relative, you may be able to get checked and learn about your risk.
This study looks at whether turning off meal announcements in automated insulin delivery systems (which adjust insulin automatically) is safe and effective for people with type 1 diabetes. It may help simplify daily diabetes management.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.